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Case series
The objective of this study was to present all cases of liver
transplantation (LT) for acute fatty liver of pregnancy
(AFLP) from 1979 through 2012 in the Netherlands and to
review the literature.
Orthotopic liver transplantation
The first case was a 30-year-old woman with a history of
two uneventful pregnancies and deliveries. In the first tri-
mester of her third pregnancy she had suffered temporarily
from hyperemesis gravidarum. In 2002, in the 25th week of
pregnancy, she presented elsewhere with jaundice, itching,
upper abdominal pain, nausea, vomiting and fatigue. She
then rapidly developed encephalopathy and disturbed clot-
ting, and had a spontaneous vaginal delivery of a boy at
25 weeks with postpartum haemorrhage. The baby died the
first day. Because bilirubin, International Normalised Ratio
(INR) and encephalopathy further deteriorated, 4 days after
delivery she was admitted to the intensive care unit of the
Leiden University Medical Centre (LUMC). There was
jaundice and severe hepatic encephalopathy with restless-
ness, and coma developed within 1 day (Opolon–Conn
stage 4, EMV score 3). No signs of chronic liver disease
and no Kaiser–Fleisher rings were present. An underlying
autoimmune disorder, viral or metabolic causes such as
Wilson disease were excluded. Abdominal Doppler ultra-
sound revealed hepatic steatosis but was otherwise normal.
A liver biopsy showed some hepatocyte necrosis and
evident steatosis, 80% microvesicular and 20% macrovascu-
lar, compatible with a diagnosis of AFLP. Laboratory and
clinical findings are shown in Table 1.
The patient fulfilled King’s College Hospital (KCH) cri-
teria for LT.1 She was placed on the high urgency waiting
list for LT and was supported by continuous venovenous
haemofiltration (CVVH) with molecular absorbent recircu-
lating system (MARS), intravenous acetylcysteine and sys-
temic cooling (35 °C) until orthotopic liver transplantation
(OLT).2 The next day she underwent OLT. Postoperatively,
she developed renal insufficiency but CVVH was not neces-
sary because renal function rapidly improved. She was dis-
charged home on day 22 after OLT without further
complications and with tacrolimus and mycophenolate
mofetil as immunosuppressants. No long-chain hydroxacyl
CoA dehydrogenase (LCHAD) mutations were detected.3
She has remained well more than 10 years after OLT, with-
out further pregnancies.
Auxiliary liver transplantation
The other woman was 35 years of age, with a history of
two spontaneous miscarriages. During her third pregnancy
she presented in 2002 at another hospital at 37 weeks ges-
tation with fatigue, drowsiness and nausea, haemodynamic
instability and intra-uterine fetal death. Delivery was
induced. Six days postpartum she was referred to LUMC
with progressive liver failure with disturbed clotting, renal
insufficiency, hypoglycaemia and haemodynamic instability.
Within a day she developed hepatic coma (Opolon–Conn
stage 4, EMV score 3) and brain oedema as evidenced by
transcranial Doppler examination. Laboratory and clinical
findings are indicated in Table 1. She did not fully comply
with KCH criteria, but serum lactate was 8.9 mmol/l.
Immediate treatment was started with CVVH with MARS,
intravenous acetylcysteine and systemic cooling (35 °C).
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Liver transplantation for acute fatty liver of pregnancy
She was placed on the high urgency waiting list for LT.
The next day, auxiliary liver transplantation (AUX) was
carried out, with a left partial graft (segments 2, 3 and half
of 4) in the left upper abdomen and a renoportal anasto-
mosis, leaving the native liver untouched, as decribed else-
where.4 An intra-operative native liver biopsy revealed
severe steatosis, mixed micro- and macrovascular
(50/50%), and was compatible with a diagnosis of AFLP.
Postoperatively, CVVH was required and critical illness
neuropathy developed. This resolved and the patient recov-
ered within 3 weeks. Both livers were regularly assessed
with hepatobiliary scintigraphy and computed tomography
with volumetry and liver biopsies. Scintigraphy showed
sufficient function of the graft and improving function of
the native liver over time, and liver biopsies showed a sig-
nificant reduction of steatosis in the native liver. This led
to removal of the auxiliary liver on day 31 after AUX. This
liver was re-used as an orthotopic graft in another recipi-
ent, as decribed elsewhere.5 Tacrolimus and prednisolone
were stopped. She went home on day 7 after graft explanta-
tion. No LCHAD mutations were found. Now, more than
10 years later, she leads a normal life with normal liver
function, without further pregnancies.
Discussion
Searching the databases from the three Dutch liver trans-
plant centres revealed that in 33 years of liver transplanta-
tion in 1979–2012 in the Netherlands, there were two cases
– one OLT and one AUX – from 2445 liver transplanta-
tions (<0.1%) for AFLP. Both had an excellent outcome.
After AUX, the graft could be removed and immunosup-
pression stopped after regeneration of the native liver. The
graft was then successfully used for OLT in another
recipient.
After obtaining permission to search in the databases of
the European Liver Transplant Registry and in the Euro-
transplant database, under-reporting and wrong coding
were found, preventing further European analysis.
AFLP can occur in the third trimester of pregnancy,
with an estimated prevalence of 1:7000–13 000 deliveries.
Maternal mortality of AFLP was 80% before 1980, and
18% in 1999, with a fetal mortality rate of 20–60%.6,7
This improvement is probably due to many factors, such
as improved intensive care and better obstetric care,
including earlier termination of pregnancy.2,6–8 Patients
often present with epigastric pain, nausea and vomiting.
Jaundice, hepatic encephalopathy, thrombocytopenia and
disturbed clotting can be present, and subcapsular hae-
matomas and liver rupture can occur. The Swansea
criteria for diagnosing AFLP were validated in a prospec-
tive study.9,10 Overlap with HELLP (haemolysis, elevated
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exist. Treatment consists in accelerated delivery with cor-
rection of clotting and of hypoglycaemia, and most
women recover. Infants receive an adjusted diet, rich in
carbohydrates and low-fat, and long-term fasting is
avoided.6,7 In acute liver failure (ALF), early CVVH with
cooling and intravenous antibiotics may reduce the inci-
dence of brain oedema, one of the major causes of death
in ALF.2 MARS is still used in ALF but has no proven
survival benefit. In contrast, plasmapheresis may be bene-
ficial in AFLP, and this may also be true for ALF in
general.11,12
Between August 2004 and August 2006 in the Nether-
lands there were 12 cases of severe maternal morbidity
from AFLP, representing 0.47% of the 2552 cases of severe
maternal morbidity from a total of 371 021 deliveries.13
This gives an incidence of AFLP of 3.2 cases per 10 000
deliveries (95% CI 1.8–5.7). In this period no women died
due to AFLP. If we extrapolate the 12 cases in these
2 years to 23 years, then this represents 23*12/2 = 138
cases of severe maternal morbidity from AFLP. In the 23-
year period 1983–2006, the maternal mortality rate from
AFLP was 0.13 per 100 000 live births (95% CI 0.05–
0.29), as reported in a retrospective study, while maternal
death from AFLP occurred in six women (one in 1995,
five in 2000–2001) from 538 cases (1%) of maternal
death.14 In four of these six cases, liver failure was men-
tioned as a cause of death. In the other two cases the
deaths were likely related to the AFLP, but with diffuse
intravascular coagulation (DIC) and with cardiac arrest as
the cause. Two LTs for AFLP were performed in the
Netherlands in 33 years; in 23 years this would be 2*23/
33 = 1.4. Assuming that the two women we transplanted
would otherwise have died, and adding the four cases of
maternal death due to liver failure from AFLP to the
above calculated incidence of LT of 1.4 in 23 years –
assuming these patients could have been saved by LT –
LT would have been required in 4 + 1.4 = 5.4 of 138
(3.9%) patients with severe morbidity from AFLP. Obvi-
ously, this is only a rough estimation: data do not span
the same years, and it was assumed that all women who
died from liver failure due to AFLP would benefit from
LT, which may not be the case. Some may have been too
sick to undergo LT. Furthermore, sepsis with jaundice and
DIC can mimic ALF, and such patients should not be
transplanted. A recent prospective study from the UK
found severe morbidity from AFLP of 31 per 106 births.15
This is in very good agreement with the severe AFLP inci-
dence found in the Netherlands of 32 per 106 births.13 In
the UK, 0.7 deaths per 106 births were due to AFLP, with
a survival-to-death ratio for AFLP of 70:1.15 Thus in all
the British cases with AFLP, including those less severe, a
maximum of 1/71 (1.4%) women may need LT. This
indeed is close to the case fatality rate for AFLP in the
UKOSS study of 1.8% (95% CI 0–9.4%).10 In the Nether-
lands we included only cases of severe AFLP in the calcu-
lation above, which explains the difference between 3.9%
and 1.4%, but the figures are within the same range.
In the UKOSS study, infant perinatal mortality in moth-
ers with AFLP was around 10%.10
In total, 11 women, including the two Dutch cases, with
LT for AFLP have been published, as summarised in
Table 1.10,16–24 Ten of the 11 survived. This may partially
be publication bias, as it is possible that non-survivors were
not published. Nevertheless, these data show that LT can
be lifesaving in very severe AFLP without recovery after ter-
mination of pregnancy. Most transplants were performed
within a week after delivery.
The decision to perform LT is a difficult one, especially as
the KCH criteria for LT in ALF apparently do not fully apply
to AFLP. This is due to aggressive correction of coagulopathy
for bleeding complications, resulting in a lower INR, where
age is below 40, and bilirubin often below 300 lmol/l, and
the interval between development of jaundice and encepha-
lopathy is usually shorter than a week.24 Our data from the
transplanted patients confirm this. Data from KCH also
showed that in women with severe maternal morbidity
requiring intensive care admission (almost all with AFLP or
hypertensive disease in pregnancy), the presence of
encephalopathy and lactic acidosis seem better than the KCH
criteria to distinguish women requiring LT from those who
will survive without LT.24 Indeed, all women transplanted
for AFLP shown in Table 1 had hepatic encephalopathy and
in the few with measured serum lactate and ammonia, these
values were elevated. This needs to be validated further.
Especially as most patients with AFLP recover after delivery,
better guidelines for indicating LT in AFLP are required.
Although OLT is the standard, an advantage of AUX for
ALF is that in the majority of surviving patients the native
liver regenerates, and withdrawal of immunosuppression is
possible within a year, with removal of the graft or graft
atrophy after deliberate chronic rejection.25,26 In haemody-
namically unstable women with ‘toxic liver syndrome’
due to cytokine release from liver necrosis, OLT may be
preferred. As severe necrosis is unusual in AFLP, AFLP
without improvement after delivery and with hepatic
encephalopathy and elevated serum lactate and ammonia
may be an ideal indication for AUX in haemodynamically
stable women, but this needs further confirmation. AUX is
a more complex operation than OLT with some more
primary malfunction and vascular complications, but it
may allow timely intervention and withdrawal of immuno-
suppression.
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